NCT04398758.
Study name | Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood (MOPAD) |
Methods | Randomised controlled trial |
Participants | Healthy newborns, < 3 weeks of age, one first‐degree relative with medically diagnosed AD N = 360 |
Interventions | "SanaCutan Basiscreme" applied all over body twice daily for 6 months (main phase) or 12 months (follow‐up phase) |
Outcomes | Cumulative incidence of children with atopic dermatitis at 6 months of age |
Starting date | 21 May 2020 |
Contact information | Dr Wehran ‐ studien@infectopharm.com PI Dr Kristen Beyer, Charité University, Berlin, Germany |
Notes |